Oragenics OGEN Estimates

NYSE OGEN
$0.51 -0.01 (-1.06%)
As of: Sep 9, 2026 · 3:54 PM EDT
Analyst Estimates

Oragenics Inc Revenue Estimates

Periods 36
Next Period Q4 22
Consensus 0.00

Analysts expect Oragenics Inc to report revenue of 0.00 for Q4 22, against a range of 0.00 to 0.00. The most recent reported quarter, Q3 22, came in at 100,000.00.

Metric Q1 22Q2 22Q3 22Q4 22Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 0.000.00100,000.00--------
High Estimate 0.000.000.000.000.000.000.000.005,624.805,543.884,756.04
Low Estimate 0.000.000.000.000.000.000.000.004,644.264,861.704,219.32
Consensus Estimate 0.000.000.000.000.000.000.000.005,134.535,202.794,487.68
Analyst Estimates

Oragenics Inc Earnings Per Share (EPS) Estimates

Periods 36
Next Period Q4 22
Consensus -76.39

Analysts expect Oragenics Inc to report earnings per share of -76.39 for Q4 22, against a range of -82.80 to -69.98. The most recent reported quarter, Q3 22, came in at -54.00, a 36.8% beat against the -85.47 consensus.

Metric Q1 22Q2 22Q3 22Q4 22Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -90.00-54.00-54.00--------
High Estimate -35.11-69.07-78.25-69.98-85.65-91.06-81.83-81.74-15.04-1.14-2.01
Low Estimate -41.77-80.55-92.69-82.80-103.45-98.58-88.47-88.64-17.36-1.34-2.17
Consensus Estimate -38.44-74.81-85.47-76.39-94.55-94.82-85.15-85.19-16.20-1.24-2.09